These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 5426474)

  • 1. [Catapresan. A new antihypertensive drug].
    Naess K; Lund-Larsen PG
    Tidsskr Nor Laegeforen; 1970 Feb; 90(4):416-9. PubMed ID: 5426474
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new hypotensive agent with central action].
    Fritel D
    Therapeutique; 1970 Nov; 46(9):893-5. PubMed ID: 5486137
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experiences with the new antihypertensive agent Catapresan].
    Messerich J
    Med Klin; 1966 Dec; 61(52):2078-9. PubMed ID: 5999213
    [No Abstract]   [Full Text] [Related]  

  • 4. [Catapresan (C. H. Boehringer Sohn)].
    Lakartidningen; 1971 Mar; 68():Suppl I:30. PubMed ID: 5556338
    [No Abstract]   [Full Text] [Related]  

  • 5. [ECG studies following oral administration of a new antihypertensive substance (Catapresan)].
    Strössenreuther H
    Med Monatsschr; 1966 Dec; 20(12):565-6. PubMed ID: 5980274
    [No Abstract]   [Full Text] [Related]  

  • 6. Some newer piperazine derivatives as hypotensive drugs.
    Agarwal JC; Gupta YK; Shanker K
    Pharmazie; 1984 Nov; 39(11):775. PubMed ID: 6531384
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of severe hypertension with Catapresan. A comparative study of the effects of Catapresan and methyldopa on ambulant hypertensive patients].
    Becker-Christensen F; Bang HO; Ditzel J
    Ugeskr Laeger; 1970 Dec; 132(49):2331-6. PubMed ID: 5488234
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience with Catapresan in the therapy of hypertension].
    Michel D
    Dtsch Med Wochenschr; 1968 Jul; 93(28):1375. PubMed ID: 5657231
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical studies on the antihypertensive effect of Catapresan].
    Kreuziger H; Brehm H
    Med Welt; 1968 Apr; 14():905-7. PubMed ID: 5718198
    [No Abstract]   [Full Text] [Related]  

  • 10. Central cardiovascular effects of flutonidine in adult fowls.
    Marmo E; Di Mezza F; Nistico G; Somma A; Ariello B; Imperatore A
    Agressologie; 1981; 22(6):269-72. PubMed ID: 7325301
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical studies on the mechanism of action of 2-(2,6-dichlorphenylamino)-2-imidazolinehydrochloric acid (Catapresan)].
    Scheja HW; Strum A
    Verh Dtsch Ges Inn Med; 1968; 74():559-62. PubMed ID: 5714381
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of imidazopyridinium derivatives as neuromuscular blocking agents.
    Bellani P; Clavenna G; Sosio A
    Farmaco Sci; 1984 Oct; 39(10):846-62. PubMed ID: 6510519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experience with Catapresan].
    Laux L; Angelmann W
    Med Monatsschr; 1967 Apr; 21(4):186-7. PubMed ID: 5584446
    [No Abstract]   [Full Text] [Related]  

  • 14. [The acute effect of ST-155 hypotensive agent, on cardiac and renal hemodynamics].
    Vorburger C; Bütikofer E; Weiss S; Diacon C
    Helv Med Acta; 1967; 34(1):Suppl:133-4. PubMed ID: 5589186
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of glaucoma with catapresan].
    Honegeer H; Wachholz E
    Klin Monbl Augenheilkd; 1971 Feb; 158(2):306-7. PubMed ID: 5555611
    [No Abstract]   [Full Text] [Related]  

  • 16. [New antihypertensive drugs for general practice from the pharmacologist's viewpoint].
    Haeusler G
    Med Welt; 1974 Dec; 25(49):2057-64. PubMed ID: 4444502
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of an imidazole derivative on arterial blood pressure, hemodynamics and ventilation].
    Kochsiek K; Fritsche H
    Arzneimittelforschung; 1966 Sep; 16(9):1154-60. PubMed ID: 6014733
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term antihypertensive therapy with moxonidine (cynt) in patients with insulin-independent diabetes mellitus].
    Lazebnik LB; Malichenko SB; Serebrov AN
    Ter Arkh; 1997; 69(6):59-64. PubMed ID: 9297279
    [No Abstract]   [Full Text] [Related]  

  • 20. Preparation of new [1,2,4]triazolo[4,3-b]pyridazines. Part 12: Studies in the field of pyridazine compounds.
    Kosáry J; Kasztreiner E; Lázár A; Sóti M
    Pharmazie; 1983 Jun; 38(6):369-71. PubMed ID: 6611639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.